(Q30379211)

13 August 2017

1 reference

25 January 2021

Pandemic influenza vaccines: meeting the supply, distribution and deployment challenges (English)

1 reference

13 August 2017

0 references

1 reference

20 June 2019

1 reference

1 September 2020

1 reference

25 January 2021

Luc Hessel

1

1 reference

PMC publication ID

4634681

13 August 2017

European Vaccine Manufacturers (EVM) Influenza Working Group

series ordinal

2

1 reference

13 August 2017

1 July 2009

7 references

Influenza and Other Respiratory Viruses

13 August 2017

13 March 2019

23 March 2019

20 June 2019

1 July 2020

1 September 2020

25 January 2021

7 references

13 August 2017

13 March 2019

23 March 2019

20 June 2019

1 July 2020

1 September 2020

25 January 2021

3

1 reference

13 August 2017

4

1 reference

13 August 2017

165-170

1 reference

Influenza vaccine supply: building long-term sustainability.

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634681

An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634681

A clinical trial of a whole-virus H5N1 vaccine derived from cell culture.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634681

Survey of vaccine distribution and delivery issues in the USA: from pediatrics to pandemics.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634681

Embracing computer modeling to address pandemic influenza in the 21st century

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634681

The macro-epidemiology of influenza vaccination in 56 countries, 1997--2003.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634681

Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a potential priming strategy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634681

Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4634681

10.1111/J.1750-2659.2009.00085.X

26 November 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PMC publication ID

4634681

13 August 2017

PubMed publication ID

19627373

1 reference

PMC publication ID

4634681